New Amsterdam Partners LLC NY cut its position in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 16.1% during the first quarter, Holdings Channel reports. The institutional investor owned 6,500 shares of the company’s stock after selling 1,250 shares during the period. New Amsterdam Partners LLC NY’s holdings in Express Scripts Holding Company were worth $428,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Transamerica Financial Advisors Inc. increased its stake in shares of Express Scripts Holding Company by 9.4% in the third quarter. Transamerica Financial Advisors Inc. now owns 29,601 shares of the company’s stock valued at $2,088,000 after buying an additional 2,543 shares during the last quarter. Smead Capital Management Inc. purchased a new stake in shares of Express Scripts Holding Company during the third quarter valued at $30,256,000. Veritas Asset Management LLP increased its stake in shares of Express Scripts Holding Company by 8.9% in the third quarter. Veritas Asset Management LLP now owns 6,198,106 shares of the company’s stock valued at $437,152,000 after buying an additional 508,751 shares during the last quarter. Airain ltd purchased a new stake in shares of Express Scripts Holding Company during the third quarter valued at $12,110,000. Finally, Oak Associates Ltd. OH increased its stake in shares of Express Scripts Holding Company by 3.4% in the third quarter. Oak Associates Ltd. OH now owns 141,298 shares of the company’s stock valued at $9,523,000 after buying an additional 4,705 shares during the last quarter. Institutional investors own 85.36% of the company’s stock.

Institutional Ownership by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)

Shares of Express Scripts Holding Company (NASDAQ ESRX) opened at 60.69 on Friday. Express Scripts Holding Company has a one year low of $57.80 and a one year high of $80.02. The stock has a market cap of $36.02 billion, a P/E ratio of 11.00 and a beta of 0.92. The firm has a 50 day moving average of $61.69 and a 200 day moving average of $67.89.

Express Scripts Holding Company (NASDAQ:ESRX) last posted its quarterly earnings data on Monday, April 24th. The company reported $1.33 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.32 by $0.01. Express Scripts Holding Company had a net margin of 2.70% and a return on equity of 24.99%. The company had revenue of $24.65 billion during the quarter, compared to analyst estimates of $24.95 billion. During the same quarter last year, the firm posted $1.22 EPS. The business’s revenue for the quarter was down .6% on a year-over-year basis. On average, equities research analysts predict that Express Scripts Holding Company will post $6.97 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This report was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another website, it was illegally stolen and republished in violation of international copyright laws. The correct version of this report can be read at https://www.dailypolitical.com/2017/06/03/new-amsterdam-partners-llc-ny-sells-1250-shares-of-express-scripts-holding-company-esrx.html.

ESRX has been the topic of several analyst reports. Morgan Stanley lowered their target price on shares of Express Scripts Holding Company from $71.00 to $52.00 and set an “underweight” rating on the stock in a report on Wednesday, April 26th. Evercore ISI lowered their target price on shares of Express Scripts Holding Company from $68.50 to $59.00 and set an “in-line” rating on the stock in a report on Wednesday, April 26th. Mizuho lowered their target price on shares of Express Scripts Holding Company from $76.00 to $61.00 and set a “neutral” rating on the stock in a report on Tuesday, April 25th. Credit Suisse Group AG reaffirmed a “buy” rating and issued a $85.00 target price on shares of Express Scripts Holding Company in a report on Thursday, February 16th. Finally, Cowen and Company lowered their target price on shares of Express Scripts Holding Company from $90.00 to $83.00 and set an “outperform” rating on the stock in a report on Tuesday, April 25th. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $71.95.

In other news, VP Phyllis S. Anderson sold 1,100 shares of the firm’s stock in a transaction dated Friday, May 19th. The shares were sold at an average price of $60.08, for a total transaction of $66,088.00. Following the completion of the transaction, the vice president now owns 11,108 shares in the company, valued at approximately $667,368.64. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 0.54% of the company’s stock.

Express Scripts Holding Company Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.